Kineta, Inc. (KA)
NASDAQ: KA · IEX Real-Time Price · USD
0.590
+0.013 (2.25%)
At close: Jul 2, 2024, 4:00 PM
0.552
-0.038 (-6.44%)
After-hours: Jul 2, 2024, 6:25 PM EDT
Kineta Market Cap
Kineta has a market cap or net worth of $7.23 million as of July 2, 2024. Its market cap has decreased by -71.08% in one year.
Market Cap
7.23M
Enterprise Value
6.48M
1-Year Change
-71.08%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since February 11, 2016, Kineta's market cap has decreased from $111.00M to $7.23M, a decrease of -93.49%. That is a compound annual growth rate of -27.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 6.80M | -81.96% |
| Dec 29, 2023 | 37.70M | 284.69% |
| Dec 30, 2022 | 9.80M | -67.87% |
| Dec 31, 2021 | 30.50M | -31.31% |
| Dec 31, 2020 | 44.40M | -61.92% |
| Dec 31, 2019 | 116.60M | -26.80% |
| Dec 31, 2018 | 159.30M | 8.37% |
| Dec 29, 2017 | 147.00M | -51.96% |
| Dec 30, 2016 | 306.00M | 175.68% |
| Feb 11, 2016 | 111.00M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genetic Technologies | 6.86M |
| ENDRA Life Sciences | 6.82M |
| Shuttle Pharmaceuticals Holdings | 6.71M |
| TransCode Therapeutics | 6.60M |
| FSD Pharma | 6.55M |
| ASLAN Pharmaceuticals | 6.47M |
| Processa Pharmaceuticals | 6.40M |
| Xenetic Biosciences | 6.27M |